China Shineway Pharmaceutical Group Limited (CSWYF) Research

China Shineway Pharmaceutical Group Limited functions as an investment holding company, primarily engaged in the development, manufacturing, and commercialization of traditional Chinese medicines. Its operations span across the People's Republic of China and Hong Kong. The company's diverse product portfolio includes contemporary Chinese medicines, supplied in formats such as soft capsules, granules, and injections, alongside traditional Chinese medicine (TCM) Formula Granules. These offerings target a wide array of therapeutic fields, including cardiovascular and cerebrovascular health, anti-viral applications, orthopedic care, pediatric medicine, women's health, and digestive system disorders. Beyond pharmaceuticals, the company also participates in the trading of agricultural goods. Established in 2004, China Shineway Pharmaceutical Group Limited has its headquarters situated in Shijiazhuang, PRC, and operates as a subsidiary of Forway Investment Limited.

Market snapshot

Symbol
CSWYF
Price
$1.00
Day change
0.00%
Market cap
$5.0B
P/E ratio
5.27x
52-week range
0.9253-1.004
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Adcock Ingram Holdings Limited (AIHLF)
  • Columbia Care Inc. (CCHWF)
  • EBR Systems, Inc. (EBRCZ)
  • Inventiva S.A. (IVEVF)
  • Kindstar Globalgene Technology, Inc. (KDGTF)
  • Kaken Pharmaceutical Co., Ltd. (KKPCF)
  • Kossan Rubber Industries Bhd (KSRBF)
  • Luye Pharma Group Ltd. (LYPHF)

Open China Shineway Pharmaceutical Group Limited (CSWYF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.